Ribavirin (1-fl-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a synthetic nucleoside which has both in vitro (2, 6, 10) and in vivo (1, 3, 5, 7) antiviral activity against a variety of ribonucleic acid and deoxyribonucleic acid viruses. The compound acts by interfering with guanidine monophosphate formation and subsequent nucleic acid synthesis (9) . It has been suggested that this inhibition would be lethal to replicating virus but would have little effect on resting cells. Some evidence for this is provided by cytotoxicity studies on uninfected cells, wherein it has been reported that even at high concentrations (1, 000 ,ug/ml), little visible cytotoxicity in terms of degenerating cells or destruction of cell monolayers was seen, although the rate of cell proliferation was effectively reduced (2, 6) .
The present report is a study of the effects of ribavirin on an in vitro persistent mumps infection. A persistent infection differs from an acute mumps infection in that there is little viral destruction of the cultures and very low levels of virus release, even though it can be demonstrated that 80% or more of the cells carry mumps virus antigens. The effects of the drug on an acute mumps infection, in which there is almost total culture destruction and high levels of released infectious virus, were also included in the study for Hemadsorption plaqUe assay, The heamndsorption plaque assay was a modification of that described by Speel et al. (8) . Almost confluent monolayers of HeLa or BHK-21 cells in plastic petri dishes (15 by 60 mm) were washed free of growth medium with calcium-and magnesittm-free phosphate-buffered saline.
Tenfold dilutions of virus in the cell culture medium were added to the dishes in 1.0-ml volumes, and the petri dishes were incubated with intermittant rocking for 1 h. The inocula were then decanted, and the monolayers were covered with an agar overlay consisting of Eagle minimal essential medium, 0.25% Noble agar, 10% heat-inactivated fetal calf serum, and antibiotics. Plates were then incubated for 48 h.
After agar removal, hemadsorption plaques were developed by covering the monolayers with 2 to 3 mt of a 0.5% chicken erythrocyte suspension for 20 min at room temperature. Monolayers were washed three times with phosphate-buffered saline containing calcium and magnesium to remove unadsorbed chicken erythrbcytes, fixed for 5 min with absolute methanol, and scored for plaques.
Antiviral acitivity. The effects of ribavirin on the following parameters of viral infection were tested: expression of cytoplasmic viral inclusions as demonstrated by direct inmunofluorescence on fixed cells, expression of surface viral antigen as demonstrated by hemadsorption, and release of infectious virus as determined by a hemadsorption plaque assay in HeLa cells.
The effect of ribavirin on hemadsorption of chicken erythrocytes to HeLa or BHK-21 cells infected with wild-type mumps virus was determined by performing the hemadsorption plaque assay with incorporation of the drug in the agar overlay at concentrations of 0, 1, 10, 100, or 500 ,g of ribavirin per ml of overlay.
Supernatant fluids were collected from a duplicate experiment with medium overlay after a 48-h incubation and assayed for released wild-type mumps virus.
Similarly, the effect of ribavirin on hemadsorption of chicken erythrocytes to persistently infected cells was determined by adding medium containing the same test concentrations of the drug to monolayers of persistently infected cells, and hemadsorption plaques were developed after a 48-h incubation. Supemnatants collected at this time were assayed for released persistent virus.
Direct immunofluorescence was performed by using fluorescein-conjugated rabbit anti-mumps sera (Flow Laboratories, Rockville Md.). Sterile 15-mm circular glass cover slips in glass petri dishes were seeded with BHK-21 cells so that almost confluent monolayers formed in 24 h. After washing the cover slips with phosphate-buffered saline, 0.02 ml of wild-type mumps virus, diluted in media to yield approximately 100 fluorescent foci, was added. The virus was allowed to adsorb for 1 h before the cover slips were agar overlayed, with the test concentrations of ribavirin incorporated in the overlay. After a 48-h incubation, the agar was removed, and the cover slips were washed with phosphate-buffered saline, allowed to air dry, and fixed with cold acetone for 5 min. After fixation, the cover slips were stained for direct immunofluorescence, mounted in 10% buffered glycerol, and observed for fluorescence with a Zeiss ultraviolet microscope. A similar experitnent in which the drug was incorporated into medium rather thah the agar overlay was performed on persistently infected cells seeded on cover slips.
To determine the effect of ribavirin exposure time on virus expression in persistently infected cells, cover slips lightly seeded with persistently infected cells were treated with 100 jig of ribavirin per ml. Cover slips were fixed and stained for imrmunofluorescence after 0, 24, 48, 72, and 96 h of exposure to the drug.
To determine the effects of drug removal on acutely and persistently intected BHK-21 cells, the various drug concentrations were incorporated in the overlay for 48 h, after which time fresh medium without ribavirin was added to the cultures. These cultures were monitored for virus reexpression for up to 72 h after drug removal.
RESULTS
Effects of ribavirin on cell replication. Cell counts showed that with increasing concentrations of ribavirmn there was a reduction in the number of viable cells both in uninfected BHK-21 and in persistently infected cell lines (Fig. 1) (B) . Symbols (ribavirin concentration): 0, no ribavirin; U, 1 pg/ ml; A, 10 pg/ml; 0, 100 pg/ml; El, 500 pg/ml. tion foci were still detected, in contrast to the complete inhibition seen with wild-type mumps virus. Since 80 to 95% of the persistently infected cells normally contain fluorescent cytoplasmic viral inclusions, it was not possible to count discrete fluorescent foci. The direct immunofluorescence was graded 4+ to 0 based on the intensity of fluorescence and the number of infected cells.
Since hemadsorption plaques and cytoplasmic fluorescence were still detected after the persistently infected cells were exposed to the drug for 48 h, monolayers were exposed to 100 ,ug of ribavirin per ml for increasing times up to 96 h to determine whether complete inhibition of cytoplasmic fluorescence could be obtained. As Table 3 shows, there was increasing loss of viral expression with increasing exposure time, but even after 96 h of exposure, a few cells still contained mumps antigen.
Effect of ribavirin removal. In the acute infection, by 24 h after drug removal there was a slight increase in cytoplasmic fluorescence, but little if any virus release or hemadsorption to surface viral receptors (Table 4) . By 48 h after removal, there was obvious virus reexpression, as demonstrated by an increase in fluorescence, hemadsorption to membrane receptors, and released virus. By 72 h after removal, virus reexpression was at the same level as the acutely infected cultures which were not exposed to ribaviin.
Ribavirin removal from persistently infected cells also resulted in virus reexpression, but the persistent virus did not recover as rapidly as the wild-type virus (Table 5) . A noticeable increase in virus expression was not detected until 72 h after drug removal. Since persistently infected cells normally release only low levels of infectious virus (1 to 100 plaque-forming units per ml), it was not possible to determine the effect of the drug on virus release.
DISCUSSION
Many enveloped ribonucleic acid viruses are susceptible to ribavirin treatment. Various studies demonstrate that ribavirin has marked in vitro activity against parainfluenza types 1 and 3, Semliki Forest virus (2, 10), influenza viruses A2 and B (10), Newcastle disease virus (2), measles virus (2, 7), and canine parainfluenza virus (6) . Therefore, it is not surprising to find that wild-type mumps virus is inhibited by ribavirin when the drug is added to the culture at the time of virus infection. Of particular importance is that these studies demonstrated that ribavirin was also effective in inhibiting the expression of the small plaque variant, persistent mumps virus. However, ribavirin was more effective in inhibiting virus expression in the acute infection than in the persistent infection, possibly due to the more rapid replication of the wild-type virus. After 48 Persistent infections with viruses are implicated in several human diseases. Because of the severe nature of these diseases, further research in the efficacy of ribavirin treatment of persistent viral infections seems warranted.
